Literature DB >> 26767389

Performance of a cylindrical diode array for use in a 1.5 T MR-linac.

A C Houweling1, J H W de Vries, J Wolthaus, S Woodings, J G M Kok, B van Asselen, K Smit, A Bel, J J W Lagendijk, B W Raaymakers.   

Abstract

At the UMC Utrecht, a linear accelerator with integrated magnetic resonance imaging (MRI) has been developed, the MR-linac. Patient-specific quality assurance (QA) of treatment plans for MRI-based image guided radiotherapy requires QA equipment compatible with this 1.5 T magnetic field. The purpose of this study was to examine the performance characteristics of the ArcCHECK-MR in a transverse 1.5 T magnetic field. To this end, the short-term reproducibility, dose linearity, dose rate dependence, field size dependence, dose per pulse dependence and inter-diode dose response variation of the ArcCHECK-MR diode array were evaluated on a conventional linac and on the MR-linac. The ArcCHECK-MR diode array performed well for all tests on both linacs, no significant differences in performance characteristics were observed. Differences in the maximum dose deviations between both linacs were less than 1.5%. Therefore, we conclude that the ArcCHECK-MR can be used in a transverse 1.5 T magnetic field.

Entities:  

Mesh:

Year:  2016        PMID: 26767389     DOI: 10.1088/0031-9155/61/3/N80

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

Review 1.  The future of image-guided radiotherapy will be MR guided.

Authors:  Julianne M Pollard; Zhifei Wen; Ramaswamy Sadagopan; Jihong Wang; Geoffrey S Ibbott
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

2.  Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.

Authors:  Brigid A McDonald; Sastry Vedam; Jinzhong Yang; Jihong Wang; Pamela Castillo; Belinda Lee; Angela Sobremonte; Sara Ahmed; Yao Ding; Abdallah S R Mohamed; Peter Balter; Neil Hughes; Daniela Thorwarth; Marcel Nachbar; Marielle E P Philippens; Chris H J Terhaard; Daniel Zips; Simon Böke; Musaddiq J Awan; John Christodouleas; Clifton D Fuller
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-12-16       Impact factor: 7.038

Review 3.  Novel methodologies for dosimetry audits: Adapting to advanced radiotherapy techniques.

Authors:  Marlies Pasler; Victor Hernandez; Núria Jornet; Catharine H Clark
Journal:  Phys Imaging Radiat Oncol       Date:  2018-03-19

4.  A clinical validation of the MR-compatible Delta4 QA system in a 0.35 tesla MR linear accelerator.

Authors:  Vimal Desai; John Bayouth; Jennifer Smilowitz; Poonam Yadav
Journal:  J Appl Clin Med Phys       Date:  2021-03-05       Impact factor: 2.102

5.  Commissioning a secondary dose calculation software for a 0.35 T MR-linac.

Authors:  Alex T Price; Nels C Knutson; Taeho Kim; Olga L Green
Journal:  J Appl Clin Med Phys       Date:  2022-02-15       Impact factor: 2.102

6.  Clinical rationale for in vivo portal dosimetry in magnetic resonance guided online adaptive radiotherapy.

Authors:  Begoña Vivas Maiques; Igor Olaciregui Ruiz; Tomas Janssen; Anton Mans
Journal:  Phys Imaging Radiat Oncol       Date:  2022-06-11

Review 7.  Medical physics challenges in clinical MR-guided radiotherapy.

Authors:  Christopher Kurz; Giulia Buizza; Guillaume Landry; Florian Kamp; Moritz Rabe; Chiara Paganelli; Guido Baroni; Michael Reiner; Paul J Keall; Cornelis A T van den Berg; Marco Riboldi
Journal:  Radiat Oncol       Date:  2020-05-05       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.